跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cytoace - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cytoace
Approved
STANDARD
Cytoace
Getwell Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d8491ebd2cc29cbd
Company
Getwell Pharmaceuticals
Type
Standard
Approval Details
Approval Id
d8491ebd2cc29cbd
Drug Approval Philippines Name
Cytoace
Product Name
Cytoace
Registration Number
DRP-5335-02
Brand Name
Cytoace
Generic Name
Cyclophosphamide
Dosage Form
Powder for IV Injection
Dosage Strength
500mg
Manufacturer
Getwell Pharmaceuticals
Importer
Ambica International Trading Corporation
Distributor
Genace Pharma Distributor
Issuance Date
24 January 2024
Expiry Date
10 January 2029
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d8491ebd2cc29cbd
Type
Standard
Back to Philippines FDA Approvals